Ratiopharm

What Ratiopharm does

Ratiopharm GmbH is a German pharmaceutical company headquartered in Ulm (Graf-Arco-Straße 3) that manufactures and distributes approximately 2,500 generic medicines (Generika) covering nearly all major therapeutic areas. Its catalog spans allergy treatments (cetirizine, loratadine, levocetirizine, desloratadine, mometasone nasal sprays, cromoglycate eye and nasal products), eye care (hyaluronic acid drops and gels), vitamins and minerals (B-complex, magnesium, biotin), topical hydrocortisone, and pain relief (Synofen), offered in both over-the-counter (rezeptfrei) and prescription (rezeptpflichtig) formats. Distribution is exclusive to the German pharmacy network (Apotheken), the country's mandated retail channel for medicines, with the company also supplying dedicated materials and product information to healthcare professionals through its Fachkreis portal.

Ratiopharm is a wholly-owned subsidiary of the international Teva Group (Teva Pharmaceutical Industries Ltd.), one of the world's leading generic and specialty pharmaceutical manufacturers. Operating as Teva's primary German-market brand, it leverages the parent's manufacturing scale, R&D and procurement leverage, while preserving the ratiopharm consumer-facing brand identity. The company pursues a multi-channel engagement model: a content-rich website (ratiopharm.de) with a Ratgeber health-guides hub and pharmacy finder (Apothekenfinder, using Google Maps integration), a presence on Facebook, Instagram, YouTube and LinkedIn, consumer mobile apps including Pollen-Radar and Rückenschule, and online self-assessment tools (Vitamintest, Biotin-Schönheits-Check). Revenue is generated through pharmacy-channel sales of OTC and prescription generics at prices set within the German statutory reimbursement framework, with margins structurally tied to generic substitution rates and statutory health-insurance tendering rather than premium pricing.

Name

Ratiopharm

Legal name

ratiopharm GmbH

Website

https://ratiopharm.de

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Ratiopharm GmbH is Germany's most recognized generic pharmaceutical brand, producing approximately 2,500 OTC and prescription medicines sold exclusively through the German pharmacy network. As a Teva Group subsidiary, it serves consumers and healthcare professionals across nearly all therapeutic areas.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Generic pharmaceuticals
• OTC medications
• Prescription medicines
• Allergy treatments
• Vitamin supplements

Headquarters

HQ city

Neu-ulm

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Generic Pharmaceutical Products: Ratiopharm generates revenue through the sale of generic pharmaceutical products, both prescription (rezeptpflichtige) and over-the-counter (rezeptfreie) medications, sold through the pharmacy network in Germany.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Ratiopharm is a German generic pharmaceutical company that manufactures and distributes approximately 2,500 products spanning nearly all therapeutic areas, available as both prescription (rezeptpflichtige) and over-the-counter (rezeptfreie) medications. Its portfolio covers allergy care (antihistamines, nasal sprays, eye drops), pain relief, vitamins and minerals, topical skin treatments, and eye care products, complemented by digital health tools such as the Pollen-Radar allergy forecasting app and the Rückenschule back exercise app. The company is a wholly-owned subsidiary of the Teva Group and operates as Germany's most well-known pharmaceutical brand.

Product overview

Ratiopharm is Germany's most well-known generic pharmaceutical brand, producing high-quality generic medicines (Generika) and innovative health solutions for over 50 years. The product portfolio encompasses approximately 2,500 products covering nearly all therapeutic areas, including allergy medications (antihistamines like Cetirizin, Loratadin, Levocetirizin, Desloratadin; nasal sprays like Mometason, ratioAllerg, Cromo; eye drops for allergies), vitamins and minerals (Vitamin B-Komplex, Magnesium, Biotin), topical treatments (Hydrocortisone creams and sprays), eye care products (Hyaluron eye drops and gel), and pain relief (Synofen). The company also offers digital health tools including the Pollen-Radar app, Rückenschule app, Vitamintest, and Biotin Schönheits-Check. Ratiopharm is part of the international Teva Group, providing access to modern research and technology. The company slogan is 'Gute Preise. Gute Besserung.' (Good Prices. Good Recovery).

Differentiator

Problem solved

Functional benefit

Brands

• ratioAllerg: Allergy relief product sub-brand, e.g., ratioAllerg Heuschnupfenspray (nasal spray for hay fever).
• Hyaluron-ratiopharm
• Cromo-ratiopharm
• Vitamin B-Komplex-ratiopharm
• Magnesium-ratiopharm
• Synofen
• Biotin-ratiopharm

Products and services

• Antihistamine allergy medications (Cetirizin-ratiopharm, Loratadin-ratiopharm, Levocetirizin-ratiopharm, Desloratadin-ratiopharm) OTC and prescription oral antihistamine tablets and syrups for relief of nasal and eye symptoms in seasonal/perennial hay fever and chronic urticaria, including child-friendly syrup formulations and non-drowsy options, for German consumers and as prescribed/dispensed by pharmacies.
• Allergy nasal sprays (ratioAllerg Heuschnupfenspray, Mometason-ratiopharm, Cromo-ratiopharm Nasenspray, NasenSpray Pur-ratiopharm PLUS, Nasenspray-ratiopharm Panthenol) OTC and prescription nasal sprays containing beclometasone dipropionate, mometasone furoate, sodium cromoglicate, or dexpanthenol for short-term symptomatic relief of hay fever and care of the nasal mucosa, distributed via German pharmacies.
• Allergy eye drops and combinations (Cromo-ratiopharm Augentropfen and Kombipackung) Eye drops and combination packs containing sodium cromoglicate for prevention and treatment of allergic conjunctivitis, available OTC through German pharmacies.
• Dry-eye care products (Hyaluron-ratiopharm Augentropfen and Gel Augentropfen) Eye drops and gel containing hyaluronic acid (0.3% in gel form) for intensive care of dry eyes, providing long-lasting moisture for dryness, post-operative care, and contact lens wearers, available via German pharmacies.
• Synofen pain relief OTC pain relief product with a triple effect (fast, strong, well-tolerated) sold through German pharmacies for adult consumers.
• Vitamin B-Komplex-ratiopharm Hard capsules containing all 8 B vitamins supporting normal energy metabolism and reduction of tiredness; free from gluten, lactose and sugar, available OTC via German pharmacies.
• Magnesium-ratiopharm 300 mg Micro-pellets with 300 mg magnesium for once-daily magnesium supplementation; sugar-free, gluten-free, lactose-free, with lemon flavor, sold OTC through German pharmacies.
• Biotin-ratiopharm 5 mg Tablets for therapy and prophylaxis of biotin deficiency, supporting healthy hair, skin, and nails, sold OTC via German pharmacies.
• Hydrocortison-ratiopharm 0.5% topical treatments (cream and spray) OTC topical cream and spray containing 0.5% hydrocortisone for the relief of non-infected inflammatory, allergic, or itchy skin conditions, distributed through German pharmacies.
• Pollen-Radar App Mobile app for iOS and Android providing pollen flight predictions for 40 pollen species, a personalized allergy diary, 7-day weather forecast, and tips for allergy sufferers, supporting Ratiopharm's allergy product portfolio and consumer engagement.
• Rückenschule App Mobile app providing exercises and tips for back health, distributed by Ratiopharm as a complementary health resource via its download center.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Partnerships

One partnership is on record.

• Teva GroupcoreStrategic or Co-development PartnerRatiopharm is a subsidiary and brand of the international Teva Group, one of the world's leading providers of generic and specialty medications. This relationship provides access to modern research and technology, a broader product portfolio, and global operational capabilities while maintaining the Ratiopharm brand identity in the German market.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Hexal: Hexal is Germany's other leading generics manufacturer (now under Sandoz/Novartis), selling ~5,000 generics through the same pharmacy channel as Ratiopharm. It is Ratiopharm's most direct head-to-head competitor in the German generics market.
• Stada Arzneimittel: Stada is a German-headquartered generics and consumer healthcare company (now owned by Bain/Cinven) with a very similar pharmacy-channel model and broad generic + OTC portfolio. Comparable in product breadth, therapeutic coverage, and brand-driven GTM.
• Aliud Pharma: Aliud is a German generics manufacturer specializing in prescription generics distributed through pharmacies, now consolidated under the Stada group. It directly competes with Ratiopharm on price in the same German pharmacy channel.
• Aurobindo Pharma (Germany): Aurobindo is one of the largest global generics manufacturers with a strong German commercial presence, competing on identical molecules to Ratiopharm through tender and pharmacy-channel supply. Pricing-led generics competitor in the same market.
• Zentiva: Zentiva is a European-focused generics manufacturer with a meaningful German footprint (formerly Sanofi generics). It competes across the same therapeutic areas as Ratiopharm via the same pharmacy-channel distribution.
• Dermapharm Holding: Dermapharm is a German pharmaceutical manufacturer focused on branded OTC and generics sold through pharmacies, with a comparable therapeutic breadth and pharmacy-channel GTM. Strategic peer in the German OTC/generics space.

Broad incumbents

• Teva Pharmaceutical Industries: Teva is Ratiopharm's parent and the world's largest generics company. Comparable because Ratiopharm functions as Teva's consumer/generics brand front in Germany, sharing pipeline and manufacturing infrastructure with the broader Teva portfolio.
• Sandoz: Sandoz (spun off from Novartis, parent of Hexal) is one of the world's largest generics companies with extensive German presence. Comparable as a broad generics incumbent whose Hexal subsidiary directly competes with Ratiopharm in Germany.
• Viatris (Mylan): Viatris (formed via Mylan-Upjohn merger) is a global generics and established-brands player with significant European operations. Overlaps with Ratiopharm across off-patent molecules and OTC supply.

Regional players

• AbZ-Pharma: AbZ-Pharma is a German generics manufacturer registered at the same Ulm address as Ratiopharm (both Teva subsidiaries). It is a sister Teva entity with the same pharmacy-channel model and product type.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ratiopharmdeutschland
• Facebookfacebook.com/ratiopharmDE
• LinkedInlinkedin.com/company/ratiopharm
• Instagraminstagram.com/ratiopharm_deutschland

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ratiopharm